Pfizer invites the public to view and listen to two webcasts of Pfizer discussions at healthcare conferences

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to two upcoming webcasts of Pfizer’s discussions at healthcare conferences:

  • Mikael Dolsten, Chief Scientific Officer, President, Worldwide Research, Development and Medical, at Citi’s 17e BioPharma Annual Conference on Wednesday, September 7, 2022 at 10:30 a.m. EDT; and
  • David Denton, CFO, Executive Vice President, at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022 at 9:10 a.m. EDT.

To view and listen to the webcasts, visit our website at www.pfizer.com/investors. Information on accessing and registering for the webcasts will be available at www.pfizer.com/investors starting today.

Transcripts and webcasts of the discussions will be made available on our website at www.pfizer.com/investors within 24 hours of the end of the live discussions and will be accessible for at least 90 days.

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring people therapies that dramatically extend and improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of healthcare products, including innovative medicines and vaccines. Every day, Pfizer colleagues work in developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. In line with our responsibility as one of the world’s leading innovative biopharmaceutical companies, we work with healthcare providers, governments and local communities to support and expand access to reliable and affordable healthcare in the whole world. For over 170 years, we’ve worked to make a difference for everyone who counts on us. We regularly post information that may be important to investors on our website at www.Pfizer.com. Also, to learn more, visit us at www.Pfizer.com and follow us on Twitter at @Pfizer and @PfizerNewsLinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Notice of Disclosure:Webcasts may include forward-looking statements regarding, among other things, expectations regarding our product pipeline, product line and product candidates, including expected regulatory submissions, data readouts, study initiations, approvals, clinical trial results and other data in development , revenue contribution, growth, performance, timing of exclusivity and potential benefits; our expected operating and financial performance, reorganizations, business plans, strategy and outlook; strategic reviews; capital allocation targets; plans and prospects for our acquisitions, divestitures and other business development activities, and our ability to successfully capitalize on these opportunities; manufacture and supply of products; and our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine (Comirnaty) and our COVID-19 oral treatment (Paxlovid), which are subject to substantial risks and uncertainties that could cause actual results differ materially from those expressed or implied by such statements. A description of these risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and its subsequent reports on Form 10-Q, including in the sections titled “Factors of Risk” and “Forward-Looking Information and Factors That Could Affect Future Results,” and in its subsequent reports on Form 8-K, all of which are filed with the United States Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

Forward-looking statements in each webcast speak only as of the date the webcast originated. Pfizer undertakes no obligation to update any forward-looking statements contained in the webcasts as a result of new information or future events or developments.

Category: Finance

Media Contact:
[email protected]
+1 (212) 733-1226

Investor contacts:
[email protected]
+1 (212) 733-4848

Source: Pfizer Inc.